News & Press

Bringing Awareness of Sun Safety and Sun Care to the Black Community

February 22, 2022

Guest blog post by Katonya Breaux, Founder, Unsun Cosmetics and MRF advocate:   I discovered moles on my face that I thought were genetic, but after a visit to the dermatologist, I found they resulted from sun damage. The typical chemical sunscreens I …

Hope in the Ocular Melanoma Journey

February 17, 2022

Guest blog post by Samantha Buirski, ocular melanoma patient, advocate and member of the CURE OM Patient Steering Committee: Being part of a rare community is challenging. As humans we believe we are in control of our destinies and our future. When you …

The First FDA Approved Treatment for Metastatic Uveal Melanoma: What It Means for the OM Community

February 11, 2022

On January 26, 2022, the U.S. Food and Drug Administration announced the approval of KIMMTRAK (tebentafusp-tebn), the first and only FDA-approved treatment for metastatic uveal melanoma, developed by Immunocore. The approval follows Phase III clinical …

Advocating Through Research Review Processes

February 11, 2022

Guest blog post by Kristin R. McJunkins, Stage III melanoma survivor and advocate: In 2008 when I was 38 years old, I was diagnosed with Stage IIIa cutaneous melanoma. After two surgeries, which included some lymph node removal, it was determined that …

A Monumental First Step in Uveal Melanoma

February 9, 2022

Guest blog post by Keith T. Flaherty, MD, Associate Professor of Medicine at Harvard Medical School, Director of Developmental Therapeutics at Massachusetts General Hospital Cancer Center and Co-Chair of the MRF’s CURE OM Scientific Steering Committee: …